Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 7
Submit an article Journal homepage
30
Views
2
CrossRef citations to date
0
Altmetric
Research Article

In vitro metabolism of human and salmon calcitonins in rat liver and kidney evaluated by liquid chromatography-tandem mass spectrometry

N. Kobayashi Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140, Japan
,
N. Yamamura Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140, Japan
,
M. Kamagata Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140, Japan
,
A. Kurihara Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140, Japan
&
T. Ikeda Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140, Japan
Pages 655-664 | Published online: 22 Sep 2008

References

  • ARVINTE, T., CUDD, A. and DRAKE, A. F., 1993, The structure and mechanism of formation of human calcitonin fibrils. Journal of Biological Chemistry, 268, 6415–6422.
  • AUSTIN, L. A. and HEAT H., 1981, Physiology and pathophysiology. New England Journal of Medicine, 304, 269–278.
  • BLOWER, P. J., PUNCHER, M. R. B., KETTLE, A. G., GEORGE, S., DORSCH, S., LEAK, A., NAYLOR, L. H. and O'DOHERTY, M. J., 1998, Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humans. European Journal of Nuclear Medicine, 25, 101–108.
  • BRAULKE, T., DITTMER, F., GOTZ, W. and VON FIGURA, K., 1999, Alteration in pancreatic immuno - reactivity of insulin-like growth factor (IGF)-binding protein (IGFBP) -6 and in intracellular degradation of I GFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice. Hormone and Metabolism Research, 31, 235–241.
  • CUDD, A., ARVINTE, T., GAINES DAS, R. E., CHINNI, C. and MACINTYRE, I., 1995, Enhanced potency of human calcitonin when fibrillation is avoided. Journal of Pharmaceutical Science, 84, 717–719.
  • FINDLAY, D. M., MICHELANGELI, V. P. and ROBINSON, P. J., 1989, Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells. Endocrinology, 125, 2656–2663.
  • FINDLAY, D. M., NG, K. W., NIALL, M. and MARTIN, T. J., 1982, Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T47D). Biochemical Journal, 206, 343–350.
  • GAGGI, R., BELTRANDI, E., DALL'OLio, R. and FERRI, S., 1985, Relationships between hypocalcaemic and anorectic effect of calcitonin in the rat. Pharmacology Research Communications, 17,209–215.
  • GALANTE, L., HORTON, R., JOPLIN, G. F., WOODHOUSE, N. J. and MACINTYRE, I., 1971, Comparison of human, porcine and salmon synthetic calcitonins in man and in the rat. Clinical Science, 40, 9–10.
  • GENNARI, C. and AGNUSDEI, D., 1994, Calcitonins and osteoporosis. British Journal of Clinical Practice, 48, 196–200.
  • Hicia, L., 1997, Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB Journal, 11, 1215–1226.
  • HOUSSAMI, S., FINDLAY, D. M., BRADY, C. L., MARTIN, T. J., EPAND, R. M., MOORE, E. E., MURAYAMA, E., TAMURA, T., ORLIWSKI, R. C. and SEXTON, P. M., 1994, Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation. Molecular Pharmacology, 47, 798–809.
  • KOBAYASHI, N., KANAI, M., SETA, K. and NAKAMURA, K., 1995, Quantitative analysis of synthetic human calcitonin by liquid chromatography-mass spectrometry. Journal of Chromatography B, 672, 17–23.
  • LOWRY, O. H., ROSEBROUGH, H. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • PONTIROLI, A. E., 1990, Intranasal administration of calcitonin and of other peptides: studies with different promoters. Journal of Controlled Release, 13, 247–251.
  • SAKAI, T., MAKIN°, H. and TANAKA, R., 1978, Increased activity of cyclic AMP phosphodiesterase from frozen—thawed rat liver. A role of lysosomal protease in enzyme activation. Biochimica et Biophysica Acta., 522, 477–490.
  • SCARPACE, P. J., NEUMAN, W. F. and RAISZ, L. G., 1977, Metabolism of radioiodinated salmon calcitonin in rats. Endocrinology, 100, 1260–1267.
  • SCHEIBER, L. B. N. and TORREGROSA, L., 1998, Evaluation and treatment of postmenopausal osteo-porosis. Seminars in Arthritis and Rheumatism, 27, 245–261.
  • SCHNEIDER, H. G., RAUE, F., ZINK, A., KOPPOLD, A. and ZIEGLE R., 1988, Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes. Molecular and Cellular Endocrinology, 58, 9–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.